Introduction to Abirapro 250mg Tablets
Abirapro 250mg Tablet contains the active substance Abiraterone Acetate. It belongs to a group of medicines known as anti-androgens or androgen biosynthesis inhibitors. It is indicated in combination with prednisone or prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC) in adult men.
Abiraterone Acetate works by selectively inhibiting a specific enzyme called CYP17 (17α-hydroxylase/C17,20-lyase), which is essential for the production of androgens (testosterone) in the testes, adrenal glands, and prostate tumor tissues themselves. Because prostate cancer cells rely on testosterone to grow and spread, blocking its production significantly slows down tumor progression, shrinks existing lesions, and helps prolong survival.
Abirapro 250mg Tablets must be used under the strict supervision of a medical oncologist or urologist. It is typically prescribed after or alongside surgical or chemical castration (gonadotropin-releasing hormone analog therapy) to ensure testosterone levels stay as low as possible.
Before initiating treatment, inform your healthcare professional if you have a history of liver problems, severe kidney disease, heart failure, high blood pressure, low blood potassium levels (hypokalemia), a history of adrenal gland issues, or recent cardiovascular conditions. Seek immediate emergency medical care if you develop symptoms of severe fluid retention (sudden swelling in limbs, rapid weight gain, shortness of breath) or signs of liver injury (yellowing eyes or skin, severe dark urine, persistent nausea).
Uses of Abirapro 250mg Tablets
Uses of Abirapro 250mg Tablets:
-
Treatment of metastatic castration-resistant prostate cancer (mCRPC) in patients who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy.
-
Treatment of mCRPC in patients whose disease has progressed during or after a docetaxel-based chemotherapy regimen.
-
Treatment of newly diagnosed metastatic high-risk castration-sensitive prostate cancer (mCSPC) in combination with androgen deprivation therapy.
Therapeutic Effects of Abirapro 250mg Tablets
Abirapro 250mg Tablets exert a profound therapeutic effect by cutting off the fuel supply to androgen-dependent prostate cancer cells. Unlike standard hormonal therapies that only block testosterone production in the testes, Abiraterone inhibits the CYP17 enzyme complex present across three distinct cellular sites: the testes, the adrenal glands, and within the prostate tumor microenvironment itself. This thorough suppression drops circulating serum testosterone to nearly undetectable levels, effectively halting the proliferation of cancerous tissues and relieving bone pain or urinary obstructions associated with advanced tumor stages.
Interaction of Abirapro 250mg Tablets with other drugs
It is important to inform your healthcare professional about all the medications you are taking, including prescription drugs, over-the-counter medications, nutritional supplements, and herbal products. Some medications may interact with Abirapro 250mg Tablets, potentially affecting their effectiveness or causing serious side effects. Notable interactions include:
-
Strong CYP3A4 Inducers (Rifampicin, Phenytoin, Carbamazepine, St. John's Wort): These can significantly lower the concentration of Abiraterone in your blood, making the treatment less effective.
-
CYP2D6 Substrates (Metoprolol, Dextromethorphan, Tramadol, Haloperidol): Abiraterone can increase the blood concentration of drugs metabolized by the CYP2D6 enzyme, increasing their risk of toxic side effects.
-
Medicines that prolong the QT interval: Caution should be exercised when taking Abirapro alongside anti-arrhythmic drugs, as androgen deprivation therapy can alter cardiac conduction parameters.
More Information about Abirapro 250mg Tablets
-
Keep out of reach of children and pets.
-
Store in a dry place at a temperature not exceeding 30°C.
-
Keep the bottle tightly closed inside its original box to protect the medication from moisture.
How to consume Abirapro 250mg Tablets
Abirapro 250mg Tablets are oral medications that must be taken on an empty stomach. Do not take these tablets with food. Taking Abirapro with food significantly alters how the medicine is absorbed, causing an unpredictable and potentially dangerous surge in drug exposure levels. Take the tablets whole with a glass of water at least 1 hour before a meal or at least 2 hours after eating. Take your dose at the exact same time every day alongside your prescribed dose of prednisone or prednisolone as instructed by your oncologist.
Safety Advice for Abirapro 250mg Tablets
Breast Feeding
Not Applicable / Unsafe Abirapro 250mg Tablets are indicated exclusively for use in male patients. However, the active ingredient passes into biological systems and is completely unsafe for women who are pregnant or breastfeeding.
Alcohol
Caution It is recommended to minimize or completely avoid alcohol consumption while taking Abirapro. Alcohol can increase the risk of liver irritation and aggravate secondary side effects like hot flashes or dizziness.
Liver
Caution Abirapro is metabolized through the hepatic pathway and can cause severe increases in liver enzymes. It should be used with extreme caution in patients with baseline moderate liver impairment, and it is contraindicated in severe hepatic disease. Routine liver function tests (LFTs) are mandatory.
Lungs
Consult Your Doctor Inform your doctor if you experience an unexpected dry cough or shortness of breath, as advanced hormonal therapies require monitoring for rare respiratory side effects or secondary fluid accumulation around the chest.
Driving
Safe Abirapro 250mg Tablets do not typically affect your ability to drive or handle machinery. However, if you experience sudden fatigue, dizziness, or muscle weakness during your course, refrain from driving until you feel fully alert.
Pregnancy
Unsafe / Contraindicated Abirapro is not for use in women. It is highly teratogenic and can cause severe fetal harm. Women who are pregnant or planning to become pregnant should avoid handling the tablets without gloves. Men undergoing treatment with pregnant partners must use a condom during sexual intercourse.
Side Effects of Abirapro 250mg Tablets
Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.
Common side effects of Abirapro 250mg Tablets are:
-
Peripheral edema (fluid retention causing swollen feet or ankles)
-
High blood pressure (hypertension)
-
Low blood potassium levels (hypokalemia)
-
Hot flashes or excessive sweating
-
Diarrhea or urinary tract infections (UTIs)
-
Joint swelling or muscle pain
Serious side effects of Abirapro 250mg Tablets are:
-
Hepatotoxicity: (Severe liver enzyme elevations, jaundice, abdominal pain, dark urine).
-
Adrenocortical Insufficiency: (Severe dizziness, profound weakness, weight loss, low blood pressure, especially if steroid therapy is suddenly stopped).
-
Cardiac Conditions: (Heart failure, irregular heartbeat/arrhythmias, severe chest tightness).
Word of Advice
Do not stop taking your companion steroid medication (Prednisone/Prednisolone) abruptly without direct orders from your oncologist, as doing so can trigger a sudden drop in your body's cortisol production, resulting in an adrenal crisis. Ensure you consistently keep your laboratory appointments for monthly checking of your blood pressure, potassium levels, and liver function panels. If you miss a scheduled dose of Abirapro on any given day, skip it entirely and take your normal single dose the following day. Do not take a double dose to compensate.
FAQs about Abirapro 250mg Tablets
Q1. Why must Abirapro 250mg Tablets always be taken strictly on an empty stomach? Taking Abirapro with even a small amount of food increases the amount of medicine absorbed by your body by up to several folds. This unpredictable increase drastically elevates your risk of experiencing severe, toxic side effects like life-threatening heart arrhythmias or severe liver damage.
Q2. Why do I need to take a steroid like Prednisone alongside Abirapro? Abirapro reduces the production of cortisol in your adrenal glands while blocking testosterone. This lack of cortisol causes your body to overproduce other hormones, leading to severe fluid retention, high blood pressure, and low potassium. Taking a daily low-dose steroid replaces the missing cortisol and prevents these complications.
Q3. How often will I need blood tests during this treatment? Your oncologist will typically order blood tests to check your liver function enzymes (ALT, AST, Bilirubin) and serum potassium levels every 2 weeks for the first 3 months of treatment, and once a month thereafter. Your blood pressure will also be checked regularly.
Q4. Can Abirapro 250mg Tablets cure advanced prostate cancer? Abirapro is not a definitive cure for prostate cancer, but it is a highly effective advanced therapy. Clinical trials have proven that it successfully shrinks tumors, drops PSA levels, significantly delays cancer progression, and extends overall survival lines in patients.
Q5. What precautions should I take at home while handling this medicine? The tablets should be stored safely in their container. If a female family member who is pregnant, or could become pregnant, needs to handle the medicine bottle or tablets, they should always wear protective gloves to prevent accidental skin absorption of the drug particles.
Fact Box of Abirapro 250mg Tablets
-
Molecule name: Abiraterone Acetate (250mg)
-
Therapeutic class: Anti-neoplastics / Hormonal Chemotherapy Agents
-
Pharmacological class: CYP17 Inhibitors (Androgen Biosynthesis Inhibitors)
-
Indications: 1. Treatment of metastatic castration-resistant prostate cancer (mCRPC). 2. Treatment of newly diagnosed high-risk metastatic castration-sensitive prostate cancer (mCSPC).
References
-
Ryan CJ, et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. https://pubmed.ncbi.nlm.nih.gov/23228172/
-
Fizazi K, et al. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. https://pmc.ncbi.nlm.nih.gov/articles/PMC5789853/
-
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Prostate Cancer. [Updated 2026]. Available from: https://www.nccn.org/
-
Food and Drug Administration (FDA). Zytiga (Abiraterone Acetate) Full Prescribing Information and Dosing Guidelines. https://www.accessdata.fda.gov/
Disclaimer
Medipoint India’s primary intention is to ensure that its consumers get accurate, trustworthy, and expert-reviewed information. The contents of this website are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Medipoint India. Our mission is to support, not replace, the doctor-patient relationship.
